Behcet's syndrome and the nervous system
暂无分享,去创建一个
[1] T. Hashimoto,et al. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome. , 1997, Clinical immunology and immunopathology.
[2] S. Totsuka,et al. Some Clinical and Pathological Problems in Neuro‐Behset's Syndrome , 1972 .
[3] P. Barnes,et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. , 1995, AJR. American journal of roentgenology.
[4] R. Sener. Neuro-Behcet's disease: diffusion MR imaging and proton MR spectroscopy. , 2003, AJNR. American journal of neuroradiology.
[5] A. Tuttolomondo,et al. Anti-tumour necrosis factor α monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet’s syndrome , 2003, Annals of the rheumatic diseases.
[6] K. Tanikawa,et al. AN AUTOPSY CASE OF CHRONIC DISSEMINATED ENCEPHALOMYELITIS COMPLICATED BY BEHCET'S SYNDROME, WITH SPECIAL REFERENCE TO THE DEMYELINATING DISEASES , 1965, Folia psychiatrica et neurologica japonica.
[7] J. Trontelj,et al. Behçet’s syndrome: a report of 41 patients with emphasis on neurological manifestations , 1998, Journal of neurology, neurosurgery, and psychiatry.
[8] G. Pozzessere,et al. Multimodal evoked potentials in neuro‐Behçet: a longitudinal study of two cases , 1989, Acta neurologica Scandinavica.
[9] J. Noseworthy. Neurological Therapeutics: Principles and Practice , 2003 .
[10] T. Lehner,et al. Recent advances in Behçet's disease , 1986 .
[11] H. Inoko,et al. The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. , 1999, American journal of human genetics.
[12] J. Baik,et al. Human α-enolase from endothelial cells as a target antigen of anti–endothelial cell antibody in Behçet's disease , 2003 .
[13] J. Roh,et al. Diffusion weighted magnetic resonance imaging in Neuro-Behçet's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[14] M. Hadfield,et al. Neuro-Behçet's disease. , 1996, Clinical neuropathology.
[15] G. Akman-Demir,et al. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. , 1999, Brain : a journal of neurology.
[16] I. Touitou,et al. Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands. , 1999, The Journal of pediatrics.
[17] S. Bahar,et al. Intracranial hypertension in Behçet's Disease * , 1996 .
[18] R. Vonthein,et al. CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications—results of a retrospective analysis of 117 cases , 2006, Clinical Rheumatology.
[19] H. Inoko,et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. , 1999, Arthritis and rheumatism.
[20] P. Vitali,et al. Brain Functional Involvement by Perfusion SPECT in Systemic Sclerosis and Behçet's Disease , 2002, Annals of the New York Academy of Sciences.
[21] H. Kikuchi,et al. Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years. , 2003, Advances in experimental medicine and biology.
[22] W. McMenemey,et al. ENCEPHALOMYELOPATHY IN BEHÇET'S DISEASE: REPORT OF NECROPSY FINDINGS IN TWO CASES , 1957 .
[23] N. Forbath,et al. THE ANTI-SMOKING CLINIC. , 1963, Lancet.
[24] U. Tursen,et al. Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease , 2002, Clinical and experimental dermatology.
[25] S. Hirohata,et al. Cerebrospinal fluid β2-microglobulin in neuro-Behçet’s syndrome , 2000, Journal of the Neurological Sciences.
[26] S. Saip,et al. Headache in Behçet's Syndrome , 2005, Headache.
[27] H. Keçeci,et al. P300 in Behcet's Patients without Neurological Manifestations , 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[28] I. Namer,et al. Peripheral Nervous System Involvement in Behçet’s Disease , 1987 .
[29] C. Heyser,et al. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] T. Hashimoto,et al. Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease , 1998, Journal of the Neurological Sciences.
[31] N. Shibata,et al. Neurological aspects of Behçet's disease. A case report and clinico-pathological review of the literature in Japan. , 1967, Journal of the neurological sciences.
[32] Y. Krespi,et al. Cerebral vasculitis and ischaemic stroke in Behçet’s disease: report of one case and review of the literature , 2001, European journal of neurology.
[33] H. Inoko,et al. Molecular genetics (HLA) of Behçet's disease. , 1997, Yonsei medical journal.
[34] H. Yazıcı,et al. Cerebral venous thrombosis is associated with major vessel disease in Behçet’s syndrome , 2004, Annals of the rheumatic diseases.
[35] O. Avci,et al. Subclinical cerebral involvement in Behçet's disease: a SPECT study , 1998, European journal of neurology.
[36] M. Takahashi,et al. An unusual case of Behçet ’ s disease presenting with bilateral internal carotid artery occlusion , 2022 .
[37] S. Goerdt,et al. Serum of Patients with Behçet’s Disease Induces Classical (Pro-Inflammatory) Activation of Human Macrophages in vitro , 2003, Dermatology.
[38] C. Berlin. BEHCET'S SYNDROME WITH INVOLVEMENT OF THE CENTRAL NERVOUS SYSTEM: REPORT OF A CASE, WITH NECROPSY, OF LESIONS OF THE MOUTH, GENITALIA AND EYES; REVIEW OF THE LITERATURE , 1944 .
[39] H. Inoko,et al. Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease. , 2002, Tissue antigens.
[40] O. Çoban,et al. Spontaneous dissection of the extracranial vertebral artery with spinal subarachnoid haemorrhage in a patient with Behçet's disease , 2004, Neuroradiology.
[41] N. Seyahi,et al. The Long-Term Mortality and Morbidity of Behçet Syndrome: A 2-Decade Outcome Survey of 387 Patients Followed at a Dedicated Center , 2003, Medicine.
[42] T. Hashimoto,et al. Mononeuritis multiplex in incomplete Behcet's disease: A case report and the review of the literature , 1989, Clinical Rheumatology.
[43] D. Hall,et al. Cytokine-induced programmed death of cultured sympathetic neurons , 1993, Neuron.
[44] P. Desmond,et al. Behçet’s disease with cerebral vasculitis , 2001, Internal medicine journal.
[45] B. Baykan,et al. Epileptic Seizures in Behçet Disease , 2002, Epilepsia.
[46] U. Otten,et al. Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials , 1997, Progress in Neurobiology.
[47] S. Abdelhak,et al. Les manifestations neurologiques de la maladie de Behet: analyse dune srie de 27 patients , 2002 .
[48] M. Accorinti,et al. Pre-symptomatic neurological involvement in Behcet's disease: the diagnostic role of magnetic transcranial stimulation. , 1996, Electroencephalography and clinical neurophysiology.
[49] N. Kocer,et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement , 2001, Journal of Neurology.
[50] B. Stigsby,et al. Transcranial magnetic stimulation in Behçet's disease: a cross-sectional and longitudinal study with 44 patients comparing clinical, neuroradiological, somatosensory and brain-stem auditory evoked potential findings , 2000, Clinical Neurophysiology.
[51] Z. Tümer,et al. Genetic anticipation in Behçet’s syndrome , 1998, Annals of the rheumatic diseases.
[52] Toshiharu Matsumoto,et al. Vasculo-Behçet's disease: a pathologic study of eight cases. , 1991, Human pathology.
[53] J. Delavelle,et al. Efficacy of TNF α blockade in cyclophosphamide resistant neuro-Behçet disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[54] Z. Amoura,et al. Neuro-Behçet's disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up. , 2003, Advances in experimental medicine and biology.
[55] P. Serdarog̃lu. Behçet’s disease and the nervous system , 1998, Journal of Neurology.
[56] P Rudge,et al. Neurological complications in Behçet's syndrome. , 1999, Brain : a journal of neurology.
[57] N. Kocer,et al. Endovascular treatment of Behçet's disease-associated intracranial aneurysms: report of two cases and review of the literature , 2003, Neuroradiology.
[58] M. Şahin,et al. Correlation of clinical, MRI and Tc-99m HMPAO SPECT findings in neuro-Behçet's disease. , 2004, Acta neurologica Belgica.
[59] G. Akman-Demir,et al. Headache in Behçet's Disease , 2006, Cephalalgia : an international journal of headache.
[60] J. C. Nichols,et al. Interferon-alpha 2a treatment of neuro-Behcet disease. , 2001, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[61] M. Vidailhet,et al. Cerebral venous thrombosis in Behçet's disease , 1992, Neurology.
[62] N. Yamakita,et al. Necrotising myositis in Behçet's disease: characteristic features on magnetic resonance imaging and a review of the literature , 2002, Annals of the rheumatic diseases.
[63] R. Monastero,et al. Prevalence of Headache in Patients with BehÇet's Disease Without Overt Neurological Involvement , 2003, Cephalalgia : an international journal of headache.
[64] G. Karataş,et al. Autonomic nervous system involvement in Behçet's disease , 2002, Rheumatology International.
[65] S. Kusunoki,et al. Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to microemulsion formulation. , 2005, Internal medicine.
[66] G. Akman-Demir,et al. Neuropsychological follow-up of 12 patients with neuro-Behçet disease , 1999, Journal of Neurology.
[67] A. Silman,et al. [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.
[68] S. Kotake,et al. Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. , 1999, Ophthalmology.
[69] Y. Itoyama,et al. Neuro-Sweet disease , 2005, Neurology.
[70] D. Kidd. The prevalence of headache in Behçet's syndrome. , 2006, Advances in experimental medicine and biology.
[71] G. Akman-Demir,et al. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases , 2003, Journal of Neuroimmunology.
[72] S. Terae,et al. Intracranial hemorrhage in neuro-Behçet's syndrome. , 2002, Internal medicine.
[73] D. Caparros-Lefebvre,et al. Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings , 2002, Journal of Neurology.
[74] S. Doğanay,et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease , 2002, The British journal of ophthalmology.
[75] J. Kooner,et al. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. , 2001, Journal of the American College of Cardiology.
[76] S. Caillat-Zucman,et al. HLA-B phenotype modifies the course of Behçet's disease in Moroccan patients. , 2003, Tissue antigens.
[77] C. Tsai,et al. Decreased Cerebral Blood Flow in Neuro‐Behcet's Syndrome Patients With Neuropsychiatric Manifestations and Normal Magnetic Resonance Imaging—A Preliminary Report , 2002, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[78] B. Silfverskiöld. RECURRENT UVEITIS (BEHCET'S SYNDROME) AND ENCEPHALOMYELOMENINGITIS , 1951 .
[79] H. Direskeneli. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51 , 2001, Annals of the rheumatic diseases.
[80] G. Espinosa,et al. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. , 2002, The American journal of medicine.
[81] N. Kocer,et al. CNS involvement in neuro-Behçet syndrome: an MR study. , 1999, AJNR. American journal of neuroradiology.
[82] N. Ashjazadeh,et al. Neuro-Behcet's disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behcet's disease in 96 Iranian patients. , 2003, Experimental and molecular pathology.
[83] K. Sharquie,et al. Prevalence and patterns of neurological involvement in Behcet’s disease: a prospective study from Iraq , 2003, Journal of neurology, neurosurgery, and psychiatry.
[84] K. Tani,et al. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. , 1985, Human pathology.
[85] Kei Yamada,et al. Neuro-Behçet disease mimicking brain tumor. , 2005, AJNR. American journal of neuroradiology.
[86] A. Osterhaus,et al. Vγ9Vδ2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens , 2002, Journal of Neuroimmunology.
[87] H. Yazici. Behçet’s syndrome: An update , 2003, Current rheumatology reports.
[88] L. Espinoza,et al. Successful treatment of long-standing neuro-Behçet's disease with infliximab. , 2005, The Journal of rheumatology.